Richard M Hoffman1, Jun Li, Jeffrey A Henderson, Umed A Ajani, Charles Wiggins. 1. Richard M. Hoffman and Charles Wiggins are with the University of New Mexico School of Medicine and the University of New Mexico Cancer Center, Albuquerque. Richard M. Hoffman is also with the New Mexico VA Health Care System, Albuquerque. Jun Li and Umed A. Ajani are with the Centers for Disease Control and Prevention (CDC), Atlanta, GA. Jeffrey A. Henderson is with the Black Hills Center for American Indian Health, Rapid City, SD.
Abstract
OBJECTIVES: We linked databases to improve identification of American Indians/Alaska Natives (AI/ANs) in determining prostate cancer death and incidence rates. METHODS: We linked prostate cancer mortality and incidence data with Indian Health Service (IHS) patient records; analyses focused on residents of IHS Contract Health Service Delivery Area (CHSDA) counties. We calculated age-adjusted incidence and death rates for AI/AN and White men for 1999 to 2009; men of Hispanic origin were excluded. RESULTS: Prostate cancer death rates were higher for AI/AN men than for White men. Death rates declined for White men (-3.0% per year) but not for AI/AN men. AI/AN men had lower prostate cancer incidence rates than White men. Incidence rates declined among Whites (-2.2% per year) and AI/ANs (-1.9% per year). CONCLUSIONS: AI/AN men had higher prostate cancer death rates and lower prostate cancer incidence rates than White men. Disparities in accessing health care could contribute to mortality differences, and incidence differences could be related to lower prostate-specific antigen testing rates among AI/AN men.
OBJECTIVES: We linked databases to improve identification of American Indians/Alaska Natives (AI/ANs) in determining prostate cancer death and incidence rates. METHODS: We linked prostate cancer mortality and incidence data with Indian Health Service (IHS) patient records; analyses focused on residents of IHS Contract Health Service Delivery Area (CHSDA) counties. We calculated age-adjusted incidence and death rates for AI/AN and White men for 1999 to 2009; men of Hispanic origin were excluded. RESULTS:Prostate cancer death rates were higher for AI/AN men than for White men. Death rates declined for White men (-3.0% per year) but not for AI/AN men. AI/AN men had lower prostate cancer incidence rates than White men. Incidence rates declined among Whites (-2.2% per year) and AI/ANs (-1.9% per year). CONCLUSIONS: AI/AN men had higher prostate cancer death rates and lower prostate cancer incidence rates than White men. Disparities in accessing health care could contribute to mortality differences, and incidence differences could be related to lower prostate-specific antigen testing rates among AI/AN men.
Authors: David K Espey; Melissa A Jim; Thomas B Richards; Crystal Begay; Don Haverkamp; Diana Roberts Journal: Am J Public Health Date: 2014-04-22 Impact factor: 9.308
Authors: Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Alvaro Páez; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Sigrid Carlsson; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Paula M Kujala; Bert G Blijenberg; Ulf-Hakan Stenman; Andreas Huber; Kimmo Taari; Matti Hakama; Sue M Moss; Harry J de Koning; Anssi Auvinen Journal: N Engl J Med Date: 2012-03-15 Impact factor: 91.245
Authors: Ruth Etzioni; Alex Tsodikov; Angela Mariotto; Aniko Szabo; Seth Falcon; Jake Wegelin; Dante DiTommaso; Kent Karnofski; Roman Gulati; David F Penson; Eric Feuer Journal: Cancer Causes Control Date: 2007-11-20 Impact factor: 2.506
Authors: Brenda K Edwards; Anne-Michelle Noone; Angela B Mariotto; Edgar P Simard; Francis P Boscoe; S Jane Henley; Ahmedin Jemal; Hyunsoon Cho; Robert N Anderson; Betsy A Kohler; Christie R Eheman; Elizabeth M Ward Journal: Cancer Date: 2013-12-16 Impact factor: 6.860
Authors: David K Espey; Charles L Wiggins; Melissa A Jim; Barry A Miller; Christopher J Johnson; Tom M Becker Journal: Cancer Date: 2008-09-01 Impact factor: 6.860
Authors: David K Espey; Xiao-Cheng Wu; Judith Swan; Charles Wiggins; Melissa A Jim; Elizabeth Ward; Phyllis A Wingo; Holly L Howe; Lynn A G Ries; Barry A Miller; Ahmedin Jemal; Faruque Ahmed; Nathaniel Cobb; Judith S Kaur; Brenda K Edwards Journal: Cancer Date: 2007-11-15 Impact factor: 6.860
Authors: Mary C White; David K Espey; Judith Swan; Charles L Wiggins; Christie Eheman; Judith S Kaur Journal: Am J Public Health Date: 2014-04-22 Impact factor: 9.308
Authors: Linda Burhansstipanov; Linda U Krebs; Lisa Harjo; Shinobu Watanabe-Galloway; Noel Pingatore; Debra Isham; Florence Tinka Duran; Loretta Denny; Denise Lindstrom; Kim Crawford Journal: J Cancer Educ Date: 2014-09 Impact factor: 2.037
Authors: Bridget M Cavanagh; Claire E Wakefield; Jordana K McLoone; Gail Garvey; Richard J Cohn Journal: J Cancer Surviv Date: 2015-09-07 Impact factor: 4.442
Authors: Sameer V Gopalani; Amanda E Janitz; Sydney A Martinez; Pamela Gutman; Sohail Khan; Janis E Campbell Journal: Epidemiology Date: 2020-03 Impact factor: 4.860
Authors: Dorothy A Rhoades; John Farley; Stephen M Schwartz; Kimberly M Malloy; Wenyu Wang; Lyle G Best; Ying Zhang; Tauqeer Ali; Fawn Yeh; Everett R Rhoades; Elisa Lee; Barbara V Howard Journal: Cancer Epidemiol Date: 2021-07-19 Impact factor: 2.890
Authors: Ken Batai; Priscilla R Sanderson; Chiu-Hsieh Hsu; Lori Joshweseoma; Dana Russell; Lloyd Joshweseoma; Jordan Ojeda; Linda Burhansstipanov; Sylvia R Brown; Delores Ami; Kathylynn Saboda; Robin B Harris Journal: J Cancer Educ Date: 2020-10-20 Impact factor: 1.771